BioSpace News Archive

American Aires Inc. announces that further to its press releases of May 9, 2022, June 23, 2022, and August 2, 2022, the Company experienced delays associated with the completion of its annual audit due to difficulties in obtaining third-party shipping data from some of the Company’s fulfillment centres.

Children’s Hospital of Philadelphia and the Philadelphia Housing Authority yesterday hosted a community event at the Lucien E. Blackwell Community Center in West Philadelphia highlighting CHOP’s expanded behavioral and mental health services offered at the new state-of-the-art Center for Advanced Behavioral Healthcare at 4601 Market Street.

The diagnostic company SphingoTec GmbH announces the introduction of novel biomarker penKid in the clinical routine management of patients on a test basis in a total of four units at the University Hospital Heidelberg and Heidelberg Kidney Center.

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2022.

Sema4 today announced that the Company has appointed Kevin Feeley as Chief Financial Officer (CFO), completing its previously announced search for the CFO position.

Todos Medical, Ltd. today announced that its Atlanta-area CLIA/CAP-certified clinical laboratory Provista Diagnostics, Inc. is now offering saliva-only MonkeyPox testing.

PaxMedica, Inc. today announced the pricing of its initial public offering of 1,545,454 shares of its common stock at a public price of $5.25 per share.

Amarin Corporation plc today announced that new REDUCE-IT data show that VASCEPA/VAZKEPA (icosapent ethyl) significantly reduced ST-segment elevation myocardial infarction (STEMI), non-ST segment elevated myocardial infarction (NSTEMI), and other MI subtypes in patients with established cardiovascular disease (CVD) or diabetes with risk factors.

The Cato T. Laurencin Regenerative Engineering Founders’ Award Promotes Advancement of Scientific Leadership and Research in the Field of Regenerative Engineering.

Pfizer Inc. and BioNTech SE announced they have completed a submission to the European Medicines Agency for a booster dose of an Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for individuals 12 years of age and older.